For households across Cambria County, a medication recall is more than a notice: it is a reason to check the bottle before the next dose.

The chlorthalidone recall covers a specific lot of blood pressure medication, but it does not mean every prescription is affected.

Inventia Healthcare Limited recalled a lot of 25-milligram chlorthalidone tablets packaged in bottles of 100.

The affected batch is RISA24002, with an expiration date of April 2027 and product code 64980-599-01.

More than 13,000 bottles were involved in the September recall, which followed a separate recall of certain lots in June.

The FDA Class II recall designation means exposure could cause temporary or medically reversible health problems, while serious harm is considered unlikely.

That classification is not a green light to ignore a possible match.

Chlorthalidone helps the body release excess salt and water, reducing blood pressure and helping manage fluid retention.

The reported problem involves dissolution, meaning the tablets did not meet specifications for how the medicine dissolves.

If a tablet does not dissolve as intended, the body may absorb less medication, potentially weakening blood pressure control.

For patients managing hypertension, even uncertainty about a daily dose deserves a prompt conversation with a professional.

Do not stop taking chlorthalidone, change your dose or throw away tablets before speaking with your pharmacist or prescriber.

If the label does not show the manufacturer or batch number, ask your local pharmacist to check the original packaging.

Patients who use pill organizers should also check the prescription bottle rather than relying on tablet appearance alone.

Anyone who feels unwell should contact a health care professional promptly.

The practical takeaway for Cambria County is simple: verify the lot, seek guidance and keep blood pressure treatment on track.